Evidence map›Paper›PMID 41282003›Full record

ReviewFrontiers in medicine2025

Drug-herb interactions: a challenge and clinical concern in primary healthcare.

Sujithra M, Rammanohar Puthiyedath, Zeena S Pillai

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sujithra MAmrita School of Ayurveda, Amrita Vishwa Vidyapeetham, Kollam, India.
Rammanohar PuthiyedathAmrita School of Ayurveda, Amrita Vishwa Vidyapeetham, Kollam, India.
Zeena S PillaiDepartment of Chemistry, Amrita Vishwa Vidyapeetham, Kollam, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary healthcare (PHC) is the first level of care that provides basic medical services to people in their own communities. Family doctors, local clinics, and community health centers fall under this category. When it comes to drug-herb interactions, PHC faces unique challenges. Herbal medicine usage is increasing globally, raising the challenge of drug-herb interactions due to simultaneous administration with modern pharmacological agents. Literature on drug-herb interactions is growing but inadequately explored in the context of primary healthcare. This mini review focuses on the concerns and challenges of drug-herb interactions in a primary healthcare setup, taking into consideration patterns, high-risk scenarios, prediction and assessment, and management strategies. It highlights the obstacles faced by primary healthcare practitioners, including time and resource limitations, resource and knowledge gaps, and difficulties in communication. In addition, it emphasizes the need for organized approaches to screen the interactions using risk assessment tools created for primary care and to enhance educational resources to ensure patient safety and medical outcomes in a community-based healthcare setting. A consolidated evidence matrix of drug-herb interactions from published research articles is included, which can serve as a one-stop reference resource at the point of care.

Indexed as

community healthdrug–herb interactionsfamily medicinepatient safetyprimary healthcare

Identifiers

PMID41282003
PMCPMC12634587

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.